dr. kalinsky on neratinib and tucatinib in her2 metastatic breast cancer
Published 6 years ago • 514 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
3:15
neratinib for metastatic breast cancer
-
1:35
dr. kalinsky on ruxolitinib plus trastuzumab in her2-positive breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
3:08
the benefits of tucatinib in her2 breast cancer
-
2:18
use of neratinib in her2-positive breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
1:20
dr. tripathy discusses neratinib in her2 breast cancer
-
1:39
dr. anders discusses the use of neratinib/capecitabine for her2-positive brain metastases
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
9:35
neratinib in her2 breast cancer
-
1:02
dr. freedman on neratinib plus capecitabine for cns disease from her2-positive breast cancer
-
1:52
dr. o’shaughnessy on the utility of tucatinib in the her2 breast cancer brain metastases
-
0:51
dr. hamilton discusses tucatinib in her2 breast cancer
-
1:09
dr. ahmed on the impact of neratinib on cns metastases in her2 breast cancer
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer